share_log

Tracon Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lincoln Park Capital Fund, LLC(8.98%),Lincoln Park Capital, LLC(8.98%), etc.

Tracon Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lincoln Park Capital Fund, LLC(8.98%),Lincoln Park Capital, LLC(8.98%)等

美股SEC公告 ·  2023/06/02 16:46
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息